MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56

Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem (2010) 8.09

Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods (2010) 6.25

Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol (2009) 6.03

Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood (2011) 5.82

miR-21: a small multi-faceted RNA. J Cell Mol Med (2009) 5.59

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med (2012) 5.46

MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46

Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature (2015) 5.15

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) (2011) 4.64

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell (2014) 4.53

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun (2011) 4.07

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle (2009) 3.68

Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One (2010) 3.50

Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci (2010) 3.35

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One (2010) 3.23

Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis (2009) 3.11

Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med (2011) 3.03

Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02

Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer (2010) 2.95

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell (2014) 2.90

Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'. Semin Immunopathol (2011) 2.78

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer (2009) 2.76

Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One (2009) 2.68

Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res (2009) 2.66

Exosomes: immune properties and potential clinical implementations. Semin Immunopathol (2010) 2.60

Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn (2011) 2.57

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One (2011) 2.57

Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer (2011) 2.56

Extracellular microRNA: a new source of biomarkers. Mutat Res (2011) 2.55

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One (2009) 2.37

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest (2013) 2.34

The mammalian ovary from genesis to revelation. Endocr Rev (2009) 2.31

Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics (2013) 2.27

Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int (2010) 2.23

Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res (2012) 2.18

Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res (2012) 2.15

Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res (2013) 2.15

Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med (2009) 2.14

Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) (2013) 2.12

Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener (2012) 2.11

Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 2.10

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res (2012) 2.10

Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics (2010) 2.04

Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol (2010) 2.01

Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One (2011) 1.98

Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res (2010) 1.96

Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem (2014) 1.92

Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer (2012) 1.92

Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics (2009) 1.84

Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One (2014) 1.83

Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci (2013) 1.81

TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene (2010) 1.81

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest (2013) 1.80

Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A (2013) 1.79

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78

MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73

Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protoc (2012) 1.71

Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood (2015) 1.70

The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol (2011) 1.67

Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol (2012) 1.65

Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics (2015) 1.65

Paracrine induction of endothelium by tumor exosomes. Lab Invest (2009) 1.63

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med (2012) 1.62

Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip (2009) 1.61

Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res (2012) 1.60

Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet (2012) 1.60

MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol (2010) 1.59

Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics (2012) 1.58

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate (2012) 1.54

Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles (2012) 1.52

Causes and consequences of microRNA dysregulation. Cancer J (2012) 1.51

Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci (2013) 1.50

Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein Cell (2012) 1.49

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48

Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol (2015) 1.44

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer (2009) 1.44

RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer (2012) 1.43

MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2011) 1.43

Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One (2012) 1.43

MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res (2012) 1.43

Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep (2012) 1.41

A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol (2014) 1.40

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med (2012) 1.40

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics (2011) 1.39

The clinical potential of microRNAs. J Hematol Oncol (2010) 1.39

Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat Commun (2015) 1.39

Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms. PLoS One (2015) 1.38

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer (2011) 1.38

Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37

Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int (2011) 1.37

miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J Clin Invest (2014) 1.36

Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med (2014) 1.35

Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany NY) (2011) 1.35

Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One (2012) 1.33

Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes (2010) 1.32

MicroRNAs: molecular features and role in cancer. Front Biosci (Landmark Ed) (2012) 1.32

Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol (2011) 2.11

Retracted Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol (2006) 2.00

Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol (2011) 1.93

Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol (2006) 1.44

Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp Cell Res (2011) 1.26

The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet (2013) 1.21

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol (2009) 1.17

Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol (2011) 1.07

Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1β production by macrophages. Am J Reprod Immunol (2011) 0.99

Modulation of T-cell CD3-zeta chain expression during normal pregnancy. J Reprod Immunol (2002) 0.91

Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components. Gynecol Oncol (2009) 0.91

Cellular response to chemotherapy and radiation in cervical cancer. Am J Obstet Gynecol (2005) 0.88

Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecol Oncol (2005) 0.87

HSP-10 in ovarian cancer: expression and suppression of T-cell signaling. Gynecol Oncol (2006) 0.86

Loss of communication in ovarian cancer. Am J Obstet Gynecol (2006) 0.85

Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers. Cancer Biomark (2011) 0.85

A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity. Cancer Res (2003) 0.81

Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. Fertil Steril (2007) 0.80

Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines. Cancer Lett (2005) 0.79

Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss (RPL). Mol Immunol (2005) 0.79

Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol (2011) 0.78

Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss. J Reprod Immunol (2004) 0.78

Genistein reverses diminished T-cell signal transduction, induced by post-menopausal estrogen levels. Am J Reprod Immunol (2009) 0.78

Endometriosis markers: immunologic alterations as diagnostic indicators for endometriosis. Reprod Sci (2007) 0.76

Urinary matrix metalloproteinases as a potential screening test for gynecologic malignancies. Gynecol Oncol (2003) 0.76

Gene expression profiling in response to estradiol and genistein in ovarian cancer cells. Cancer Genomics Proteomics (2009) 0.76

Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels. Immun Ageing (2009) 0.75

Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation. Fertil Steril (2005) 0.75

Midluteal matrix metalloproteinase and tissue-inhibiting metalloproteinase plasma levels after embryo transfer. Fertil Steril (2004) 0.75

Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss. Am J Reprod Immunol (2012) 0.75

Comparisons of matrix metalloproteinase 1, 2, and 9 activity in periovulatory follicular fluid from natural and stimulated menstrual cycles. Fertil Steril (2006) 0.75

Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas. Fertil Steril (2006) 0.75